Single User License
INR 96720
Site License
INR 193440
Corporate User License
INR 290160

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Versartis, Inc.-Product Pipeline Review-2015

Versartis, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC06865CDB
  • |
  • Pages: 28
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Versartis, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Versartis, Inc.-Product Pipeline Review-2015', provides an overview of the Versartis, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Versartis, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Versartis, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Versartis, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Versartis, Inc.'s pipeline products

Reasons To Buy

Evaluate Versartis, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Versartis, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Versartis, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Versartis, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Versartis, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Versartis, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Versartis, Inc. Snapshot 4

Versartis, Inc. Overview 4

Key Information 4

Key Facts 4

Versartis, Inc.-Research and Development Overview 5

Key Therapeutic Areas 5

Versartis, Inc.-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Pipeline Products-Combination Treatment Modalities 9

Versartis, Inc.-Pipeline Products Glance 10

Versartis, Inc.-Late Stage Pipeline Products 10

Phase III Products/Combination Treatment Modalities 10

Versartis, Inc.-Clinical Stage Pipeline Products 11

Phase I Products/Combination Treatment Modalities 11

Versartis, Inc.-Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Versartis, Inc.-Drug Profiles 13

somatropin 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

Undisclosed Drug 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

VRS-859 + AMX-808 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Versartis, Inc.-Pipeline Analysis 17

Versartis, Inc.-Pipeline Products by Target 17

Versartis, Inc.-Pipeline Products by Route of Administration 18

Versartis, Inc.-Pipeline Products by Molecule Type 19

Versartis, Inc.-Pipeline Products by Mechanism of Action 20

Versartis, Inc.-Recent Pipeline Updates 21

Versartis, Inc.-Dormant Projects 25

Versartis, Inc.-Locations And Subsidiaries 26

Head Office 26

Appendix 27

Methodology 27

Coverage 27

Secondary Research 27

Primary Research 27

Expert Panel Validation 27

Contact Us 27

Disclaimer 28

List of Tables

Versartis, Inc., Key Information 4

Versartis, Inc., Key Facts 4

Versartis, Inc.-Pipeline by Indication, 2015 6

Versartis, Inc.-Pipeline by Stage of Development, 2015 7

Versartis, Inc.-Monotherapy Products in Pipeline, 2015 8

Versartis, Inc.-Combination Treatment Modalities in Pipeline, 2015 9

Versartis, Inc.-Phase III, 2015 10

Versartis, Inc.-Phase I, 2015 11

Versartis, Inc.-Preclinical, 2015 12

Versartis, Inc.-Pipeline by Target, 2015 17

Versartis, Inc.-Pipeline by Route of Administration, 2015 18

Versartis, Inc.-Pipeline by Molecule Type, 2015 19

Versartis, Inc.-Pipeline Products by Mechanism of Action, 2015 20

Versartis, Inc.-Recent Pipeline Updates, 2015 21

Versartis, Inc.-Dormant Developmental Projects,2015 25

List of Figures

Versartis, Inc.-Pipeline by Top 10 Indication, 2015 6

Versartis, Inc.-Pipeline by Stage of Development, 2015 7

Versartis, Inc.-Monotherapy Products in Pipeline, 2015 8

Versartis, Inc.-Pipeline by Top 10 Target, 2015 17

Versartis, Inc.-Pipeline by Top 10 Route of Administration, 2015 18

Versartis, Inc.-Pipeline by Top 10 Molecule Type, 2015 19

Versartis, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Versartis, Inc.; Versartis, Inc. - Key Therapeutics; Versartis, Inc. - Pipeline Overview and Promising Molecules; Versartis, Inc. - News; Versartis, Inc. - Latest Updates; Versartis, Inc. - Pipeline; Versartis, Inc. - Discontinued/Dormant Projects

Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]